Dr. Alexandre Rene Carter, MD

Dr. Carter practices at The Rehabilitation Institute of St. Louis in Saint Louis, Missouri, part of Encompass Health.

Dr. Carter's NPI, 1235343534, was assigned on May 9, 2007. Dr. Carter graduated from Harvard Medical School in 2003. Dr. Carter holds Missouri license 2007033981.

Dr. Carter's primary practice is The Rehabilitation Institute of St. Louis, at 4455 Duncan Ave, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 658-3800.

Dr. Carter's primary practice is The Rehabilitation Institute of St. Louis in Saint Louis, Missouri, part of Encompass Health. Dr. Carter is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Carter to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carter practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Carter's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Carter is licensed in Missouri.

CMS data shows 637 Medicare services from Dr. Carter across 8 procedure codes in 2024, for 191 Medicare patients. Medicare paid $41,772 for them.

CMS counts 191 Medicare patients who saw Dr. Carter in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carter's median patient age at 67, with 45% women.

In 2024, Dr. Carter wrote 1,153 Medicare Part D claims for 136 patients. 86% of them were for generic drugs. CMS names the drug for 822 of them, across 27 drugs with 11 or more claims each, at $113,606 in total drug cost. In 2023, CMS named 864 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Carter for performance year 2024, reported as part of a group. Dr. Carter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carter as offering telehealth.

Dmand AI links 15 papers to Dr. Carter, published from 2019 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Stroke, Magnetic Resonance Imaging and Stroke Rehabilitation. Dr. Carter has published most often in Neurorehabil Neural Repair. Dr. Carter's most frequent co-authors are Eric Claude Leuthardt, MD, Timothy Otto Laumann, MD and Carl David Hacker, MD, PhD.

CMS Open Payments shows 5 general payments to Dr. Carter from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Microtransponder, Inc. paid the most, $153.

Dr. Carter graduated from Harvard Medical School in 2003.